DemirtolaAİMammadliAÇiçekG.The role of magnesium levels in the progression of contrast-induced nephropathy in patients with STEMI undergoing primary PCI. Angiology. 2025;76:572–9.
2.
HeHChenXRChenYQNiuTSLiaoYM.Prevalence and predictors of contrast-induced nephropathy (CIN) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI): a meta-analysis. J Interv Cardiol. 2019;2019:2750173.
3.
UğuzEKurtulAŞenF.Effect of carvedilol versus metoprolol on contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous intervention therapy. Angiology. 2024;75:323-30.
4.
ShamsMDehghanPHosseinpanahF.Metformin and intravascular contrast media: what to do in patients receiving both: a narrative review. Nov Biomed. 2017;5:138-45.
5.
NieYFanLSongQWuF.Contrast media volume to creatinine clearance ratio in predicting nephropathy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Angiology. 2023;74:545-52.
6.
YangHGuoXZhangX, et al. The relationship between mean arterial pressure and decreased glomerular filtration rate in rural areas of Northeast China. BMC Nephrol. 2015;16:137.
7.
DemirkıranAAydınCÖrünSKaplangörayM.Can the SYNTAX score predict mortality in patients with cardiac arrest?Rev Assoc Med Bras (1992). 2024;70:e20240647.
